Previous Close | 40.94 |
1-Year Change | 19.67% |
6-Months Change | 71.51% |
3-Months Change | 17.91% |
Moving Avg (50d) | 35.911 |
Moving Avg (200d) | 28.614 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.0B |
Beta (3-Years) | 1.25 |
Revenue Growth (ttm) | 16.55% |
Net Profit Margin (ttm) | -9.61% |
Return On Assets (ttm) | -7.34% |
EPS (ttm) | -0.95 |
PE Ratio (ttm) | -43.09 |
Dividend Yield | % |
Asset Description: | AtriCure, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-12-05 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
41.759 | 42.987 | 43.806 | 45.034 | 47.081 | 49.128 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |